Painkiller developer Collegium Pharmaceutical has agreed to pay $2.75 million to settle more than two dozen opioid-related lawsuits.
Collegium (Nasdaq: COLL) also agreed to pay the state of Massachusetts $185,000 and stop marketing its opioids in person earlier this month, resolving allegations of what Attorney General Maura Healey described as "unfair and deceptive practices."
WATCH ANYTIME FOR FREE
Stream NBC10 Boston news for free, 24/7, wherever you are. |
More on this story from Boston Business Journal
Get updates on what's happening in Boston to your inbox. Sign up for our News Headlines newsletter.
Copyright Boston Business Journal